Portfolio company
Satellite Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
LyGenesis
LyGenesis develops regenerative cell therapies that use lymph nodes as bioreactors to grow functioning organs for patients with end-stage organ failure.
IVIVA Medical
This company develops bioartificial implantable kidneys for patients with end-stage renal disease using 3D printing and stem cell technology.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
eGenesis
This company develops genetically engineered pig organs for patients suffering from organ failure and requiring transplantation.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Avery Therapeutics
Avery Therapeutics develops tissue-engineered heart grafts to treat patients with chronic heart failure.
